Researchers made a “huge breakthrough” when they did an experiment “purely out of curiosity” which solves “a decades-long ...

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

The human genome is like a big ball of yarn, made up of 3 billion molecular units arranged in sequence and then wrapped up ...

"We built our platform to systematically address transcription factors, a target class long considered out of reach for small-molecule therapeutics," said Alex Federation, PhD, CEO and Co-Founder of ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

In further support of that finding, the researchers determined—with the help of AI—that PHGDH plays a previously undiscovered ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Ingrida Domarkienė, a geneticist at Vilnius University in Lithuania, discusses the exciting developments made possible by ...